Literature DB >> 18092844

Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) with absence of desmoglein 1 and 3 antibodies: case report and literature review.

Matteo Bordignon1, Edoardo Zattra, Maria Cristina Montesco, Mauro Alaibac.   

Abstract

Subcorneal pustular dermatosis (SPD) [Sneddon-Wilkinson disease] is a benign and uncommon disorder characterized by a chronic, relapsing vesiculopustular eruption of unknown etiology. We present a case of SPD in a young Black woman in whom ELISA was performed to test for desmoglein 1 and 3 antigens (the first reported case of evaluation for these antigens in a patient with SPD). The test revealed the absence of both antibodies. The patient was successfully treated with topical corticosteroids and narrow-band UVB phototherapy. In this report, we review both the pathophysiology of SPD, which has yet to be clarified, and its treatment. Data obtained from our case report add further support to the hypothesis that a non-antibody-mediated mechanism is operative in SPD. The treatment of choice for SPD is dapsone. However, the combination of corticosteroids and UVB phototherapy should be considered a valid therapeutic option in patients who are not appropriate candidates for dapsone therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18092844     DOI: 10.2165/00128071-200809010-00006

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  3 in total

1.  Subcorneal pustular dermatosis an immnohisto-pathological perspective.

Authors:  Ana Maria Abreu Velez; J Graham Smith; Michael S Howard
Journal:  Int J Clin Exp Pathol       Date:  2011-06-03

2.  First presentation of Sneddon-Wilkinson disease with unexpected immunoglobulin A gammopathy: A case report and review of the literature.

Authors:  Julia Mayba; C Nicole Hawkins
Journal:  SAGE Open Med Case Rep       Date:  2019-01-30

3.  Subcorneal Pustular Dermatosis in Paediatrics: A Case Report and Review of the Literature.

Authors:  Mais A Alhafi; Mohamed I Janahi; Zainab N Almossalli
Journal:  Cureus       Date:  2021-12-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.